Literature DB >> 19561440

Rapidly progressive dementia: causes found in a Greek tertiary referral center in Athens.

Sokratis G Papageorgiou1, Theodoros Kontaxis, Anastasios Bonakis, Georgios Karahalios, Nikolaos Kalfakis, Demetrios Vassilopoulos.   

Abstract

Dementia is generally considered as rapidly progressive [rapidly progressive dementia (RPD)], in cases with overt cognitive impairment, established within months. Data about the relative frequency of underlying diseases in cases of RPD are few and extremely variable, depending on the clinical setting. We examined the relative frequency of the underlying causes of RPD, in a university tertiary referral center, in Athens. A series of consecutive patients presenting with RPD in a 3-year period was included. All patients received a comprehensive clinical, imaging, and laboratory evaluation. Of a total of 279 patients hospitalized for dementia diagnosis, 68 patients had RPD (37 males and 31 females). Mean age at onset +/-SD was 65.5+/-10.0. The most common cause of RPD was secondary dementias, accounting for 18 cases (26.5%). Alzheimer disease and frontotemporal dementia were almost equally represented, accounting for 12 (17.6%) and 11 (16.2%) cases, respectively. Vascular dementia, Creutzfeldt-Jakob disease, and various neurodegenerative diseases accounted for 9 cases each (13.2%). In a tertiary referral center, secondary dementias represented the most frequent cause of cases presenting with RPD. As a substantial number of these cases are potentially treatable, our finding reconfirms and underscores the importance of an exhaustive evaluation in any case presenting with RPD.

Entities:  

Mesh:

Year:  2009        PMID: 19561440     DOI: 10.1097/WAD.0b013e31819e099b

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  17 in total

Review 1.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

2.  Differential diagnosis of Jakob-Creutzfeldt disease.

Authors:  Ross W Paterson; Charles C Torres-Chae; Amy L Kuo; Tim Ando; Elizabeth A Nguyen; Katherine Wong; Stephen J DeArmond; Aissa Haman; Paul Garcia; David Y Johnson; Bruce L Miller; Michael D Geschwind
Journal:  Arch Neurol       Date:  2012-12

Review 3.  Hashimoto's encephalopathy: a brief review.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

4.  Thorough work-up and new diagnostic criteria needed for CJD.

Authors:  David C Perry; Michael D Geschwind
Journal:  Nat Rev Neurol       Date:  2011-09-05       Impact factor: 42.937

5.  Glioblastoma with Gliomatosis Cerebri Growth Pattern Presenting as Rapidly Progressive Dementia.

Authors:  John Y Rhee; Luis Nicolas Gonzalez Castro
Journal:  Neurohospitalist       Date:  2022-02-11

Review 6.  Rapidly Progressive Dementia.

Authors:  Gregory S Day
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

7.  Diagnosis and treatment of rapidly progressive dementias.

Authors:  Ross W Paterson; Leonel T Takada; Michael D Geschwind
Journal:  Neurol Clin Pract       Date:  2012-09

Review 8.  Rapidly Progressive Dementia.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2016-04

9.  Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions.

Authors:  Gregory S Day; Erik S Musiek; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

10.  Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.

Authors:  Oriol Grau-Rivera; Raquel Sánchez-Valle; Albert Saiz; José Luis Molinuevo; Reyes Bernabé; Elvira Munteis; Francesc Pujadas; Antoni Salvador; Júlia Saura; Antonio Ugarte; Maarten Titulaer; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.